These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

975 related articles for article (PubMed ID: 25053345)

  • 21. Dual responsive micelles capable of modulating miRNA-34a to combat taxane resistance in prostate cancer.
    Lin F; Wen D; Wang X; Mahato RI
    Biomaterials; 2019 Feb; 192():95-108. PubMed ID: 30447399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
    Yang F; Li QJ; Gong ZB; Zhou L; You N; Wang S; Li XL; Li JJ; An JZ; Wang DS; He Y; Dou KF
    Technol Cancer Res Treat; 2014 Feb; 13(1):77-86. PubMed ID: 23862748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-181a promotes docetaxel resistance in prostate cancer cells.
    Armstrong CM; Liu C; Lou W; Lombard AP; Evans CP; Gao AC
    Prostate; 2017 Jun; 77(9):1020-1028. PubMed ID: 28485104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-195 regulates docetaxel resistance by targeting clusterin in prostate cancer.
    Ma X; Zou L; Li X; Chen Z; Lin Q; Wu X
    Biomed Pharmacother; 2018 Mar; 99():445-450. PubMed ID: 29665645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
    Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
    Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
    J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in patients with hormone-refractory prostate cancer.
    Tolcher AW; Kuhn J; Schwartz G; Patnaik A; Hammond LA; Thompson I; Fingert H; Bushnell D; Malik S; Kreisberg J; Izbicka E; Smetzer L; Rowinsky EK
    Clin Cancer Res; 2004 Aug; 10(15):5048-57. PubMed ID: 15297406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells.
    Fujita Y; Kojima T; Kawakami K; Mizutani K; Kato T; Deguchi T; Ito M
    Prostate; 2015 Oct; 75(14):1568-78. PubMed ID: 26074357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy.
    Zhang HL; Yang LF; Zhu Y; Yao XD; Zhang SL; Dai B; Zhu YP; Shen YJ; Shi GH; Ye DW
    Prostate; 2011 Feb; 71(3):326-31. PubMed ID: 20842666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.
    Liang J; Li Y; Daniels G; Sfanos K; De Marzo A; Wei J; Li X; Chen W; Wang J; Zhong X; Melamed J; Zhao J; Lee P
    Mol Cancer Res; 2015 Apr; 13(4):681-8. PubMed ID: 25587085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
    Foj L; Ferrer F; Serra M; Arévalo A; Gavagnach M; Giménez N; Filella X
    Prostate; 2017 May; 77(6):573-583. PubMed ID: 27990656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MitomiRs in human inflamm-aging: a hypothesis involving miR-181a, miR-34a and miR-146a.
    Rippo MR; Olivieri F; Monsurrò V; Prattichizzo F; Albertini MC; Procopio AD
    Exp Gerontol; 2014 Aug; 56():154-63. PubMed ID: 24607549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer.
    Lin HM; Castillo L; Mahon KL; Chiam K; Lee BY; Nguyen Q; Boyer MJ; Stockler MR; Pavlakis N; Marx G; Mallesara G; Gurney H; Clark SJ; Swarbrick A; Daly RJ; Horvath LG
    Br J Cancer; 2014 May; 110(10):2462-71. PubMed ID: 24714754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.
    Casanova-Salas I; Rubio-Briones J; Calatrava A; Mancarella C; Masiá E; Casanova J; Fernández-Serra A; Rubio L; Ramírez-Backhaus M; Armiñán A; Domínguez-Escrig J; Martínez F; García-Casado Z; Scotlandi K; Vicent MJ; López-Guerrero JA
    J Urol; 2014 Jul; 192(1):252-9. PubMed ID: 24518785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
    Barceló M; Castells M; Bassas L; Vigués F; Larriba S
    Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
    Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.
    Frères P; Josse C; Bovy N; Boukerroucha M; Struman I; Bours V; Jerusalem G
    J Cell Physiol; 2015 Feb; 230(2):473-81. PubMed ID: 25078559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes.
    Zhong S; Chen X; Wang D; Zhang X; Shen H; Yang S; Lv M; Tang J; Zhao J
    Oncotarget; 2016 Apr; 7(15):19601-9. PubMed ID: 26910922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells.
    Karabulut B; Erten C; Gul MK; Cengiz E; Karaca B; Kucukzeybek Y; Gorumlu G; Atmaca H; Uzunoglu S; Sanli UA; Baran Y; Uslu R
    Cell Biol Int; 2009 Feb; 33(2):239-46. PubMed ID: 19103299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.